Bovine mastitis may be associated with the deprivation of gut Lactobacillus. C. Ma, J. Zhao, X. Xi, J. Ding, H. Wang, H. Zhang and L.Y.

Similar documents
השפעת חיידקים פרוביוטיים

The Gut Microbiome: 101 Justin Carlson University of Minnesota

ESTABLISHMENT AND DEVELOPMENT OF LACTIC ACID BACTERIA AND BIFIDOBACTERIA MICROBIOTA IN BREAST-MILK AND THE INFANT GUT

The impact of the microbiome on brain and cognitive development

Government Gazette Staatskoerant

PROBIOTIC RESEARCH REVIEW

EFFECTS OF ALETA IN PROMOTING THE GROWTH OF PROBIOTIC BACTERIA: IN VITRO STUDY

Strategic application of direct-fed microbials to livestock for growth efficiency and production

Table S1. Overview of most studies on impact of ingested bacteria on human gut microbiota using methodologies not based on sequencing approaches

HMP is lead by NIH but is an International Consortium.

Analysis of the effect of probiotics on shaping human gut microbiota

Prebiotics, probiotics and synbiotics: An update

More than a gut feeling: How the microbiota improves health

Seppo Salminen Mimi Tang

INDEX. THT company history Your bacteria producer Probiotics - pure culture Probiotics - formulations and finished products...

9/18/2018. The Physiological Roles of the Intestinal Microbiota. Learning Objectives

THE HEALTHY GUT FOR AGING WELL

Emerging Probiotic Research: A Guide to the Use of Probiotics in Clinical Practice

Slide 1 THE HEALTHY GUT FOR AGING WELL. Slide 2 Aging. Slide 3 Aging

The role of nutrition in optimum gastrointestinal health

Probiotics and Prebiotics: Frequently Asked Questions

HMF Probiotics PROFESSIONAL PRODUCT GUIDE

Normal Human Flora. (Human Microbiome) Dr.Sarmad M.H. Zeiny Baghdad College of Medicine

Specific duodenal and faecal bacterial groups associated with. paediatric coeliac disease

PROBIOTIC BACTERIA AS YOGHURT STARTER AND ITS IMPLICATION EFFECT TO THE PATHOGENIC AND NON PATHOGENIC BACTERIA IN MICE GASTROINTESTINAL

GOAT MILK OLIGOSACCHARIDES PURIFICATION AND SELECTED BIFIDOBACTERIA CARBOHYDRATE UTILISATION Caroline Thum, PhD student

Probiotics: Their Role in Medicine Today. Objectives. Probiotics: What Are They? 11/3/2017

INDIVIDUAL STUDY SYNOPSIS LINPT01. EudraCT No

Modulating the gut microbiota for better health. SP4 Klaudyna Borewicz 30/11/2017

SCIENTIFIC OPINION. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) 2. European Food Safety Authority (EFSA), Parma, Italy

Formulations and Availability 900 BILLION 5,319 HIGH POTENCY PROBIOTIC PEDIATRIC ADULT GERIATRIC PROVEN BY RESEARCH. HIGH-POTENCY. NO SHORTCUTS.

PROBIOTICS NEGATIVE ASPECTS

Probiotics: Targeting obesity

Shifts in the Intestinal Microbiota

Study summaries L. casei 431

Role of commercial probiotic strains against human pathogen adhesion to intestinal mucus

The Infant Gut Microbiome: Evidence for Obesity Risk and Dietary Intervention

Module Four: The GI System Module Five: The Gut Microbiome. The GI System. LLiana Shanti, CN

The role of gut microbiome in IBS

Ther-Biotic Complete. Broad-spectrum synergistic multispecies probiotic formula. Supporting essential intestinal microdiversity

Microbiota and mental health: gut bacteria influences brain structure and behaviour. Jane A. Foster, PhD

Prevention and Therapy of Antibiotic Associated Diarrhea (ADD) through Probiotics

EED INTERVENTIONS 3.0

The importance of balance: Matching science with advocacy to encourage enlightened regulation. Dr Alex Y. Teo, Director of Scientific Affairs

INTESTINAL MICROBIOTA EXAMPLES OF INDIVIDUAL ANALYSES

bifidobacteria Genus Bacteroides fragilis Non-specific longum, B. breve and B. longum bv. Infantis CGACGATCCCAGAGATGG Bifidobacterium longum and

EED INTERVENTIONS: PRE- AND PRO-BIOTIC SAFETY

Natural and Holistic Medicine Approach in Evaluation and Treatment of Vaginal and Urinary Tract Health

Understanding probiotics and health

Probiotics and Health

Probiotics in Pediatric Health. AANP Annual Convention

Original Article. Tiengrim S 1 Manatsathit S 2 Leelaporn A 3 Ogata K 4 Yuki N 4 Asahara T 4 Thamlikitkul V 1 ABSTRACT

HMF Probiotics PROFESSIONAL PRODUCT GUIDE

Trend and Innovation of Pro and Prebiotics in Dairy Industry

A direct and sensitive method for screening fructooligosaccharides-digesting microorganisms useful in food and health science

Discussion Group 1: Where pathogenesis and commensalism meet

Intestinal colonization in premature and very low birth weight infants: Influencing factors and necrotizing enterocolitis (NEC)

PROBIOTICS IN THE FIRST 1000 DAYS

Probiotic in Indonesia : Local issue Indigenous Probiotic Research

Hygiene Hypothesis: 10 years later. Christina Ciaccio MD, MSc Assistant Professor The University of Chicago

GUT MICROBIOME WHAT IS IT? WHY IS IT IMPORTANT FOR HUMAN HEALTH?

!Microbiology Profile, stool

Issue 3, September usio

Modulation of bacterial community and metabolome in whole crop corn silage by inoculating homo- or heterofermenters

Center For Holistic Healthcare & Education

Increasing barrier function with multispecies probiotics

Choosing the Right Probiotic

A comprehensive review on Probiotics

The Gut Factor. Probiotics, the gut microbiome and human health. Thursday November 10, 2016 l 12:00 pm

PROBIOTICS. The Ultimate Flora Difference

Lactobacillus bulgaricus

Molecular Analysis of the Intestinal Microflora in IBD. Gerald W. Tannock

2/3/2011. Adhesion of Bifidobacterium lactis HN019 to human intestinal

Quality control of probiotics, the ESLP initiative

LET S TALK BUGS! THE ROLE OF PROBIOTICS IN PATIENT HEALTH AND DISEASE PREVENTION. Dragana Skokovic-Sunjic RPh BScPhm NCMP

Supplementary Table 1. Identification of bacterial sequences in different manure samples.

Bile Salt Hydrolase Activity and Resistance to Toxicity of Conjugated Bile Salts Are Unrelated Properties in Lactobacilli

Probiotics for Disease Prevention and Amelioration. Neerja Hajela, PhD Yakult Danone India Pvt. Ltd.

Mechanism of the Acid Tolerance Response in Lactobacillus Bulgaricus. Yanling Hao

AUTOIMMUNITY AND THE GUT

ANTIBIOTIC ALTERNATIVES FOR YOUNGSTOCK

Industrialized lifestyle:

The human microbiome and how it affects heath. Nafisa M. Jadavji, PhD

Next generation of probiotics

Probiotics as Living Drugs to Resolve Urinary Tract Infections

VITAMINS, MINERALS AND THE GUT

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

The Intestinal Microbiota and the Developing Immune System

Identification of bacterial strains in seven probiotic products using 16S DNA sequencing

PROBIOTICS IN HUMAN NUTRITION. Agnieszka Chlebicz Katarzyna Śliżewska

Immunity & Metabolism Human Microbiome Systems Nutrition. Food Bioactives Asian Consumers

Understanding Today s Probiotics Regulations in South East Asia. Wai Mun Poon Regulatory Affairs Consultant

MINIREVIEWS. Ecological Role of Lactobacilli in the Gastrointestinal Tract: Implications for Fundamental and Biomedical Research.

7/30/2018. Nutricia North America 1. Learning Objectives

Probiotics. NOW Guide to Probiotics

Manipulating the gut microbiome

Q What are Probiotics?

Participants. probiotic. /placebo)

Probiotics: Implications for Pediatric Health

Microbial DNA qpcr Array Metabolic Disorders

Transcription:

Supplementary online material of Beneficial Microbes DOI: http://dx.doi.org/10.3920/bm2015.0048. Bovine mastitis may be associated with the deprivation of gut Lactobacillus C. Ma, J. Zhao, X. Xi, J. Ding, H. Wang, H. Zhang and L.Y. Kwok* Table S1. Somatic cell count (SCC) of milk samples. Health and subclinical mastitis group Mastitis group Cow number SCC ( 10 3 /ml) Cow number SCC ( 10 3 /ml) 1 18 37 1,049 2 25 38 1,087 3 29 39 1,102 4 31 40 1,225 5 31 41 1,399 6 33 42 1,525 7 33 43 1,756 8 36 44 1,759 9 37 45 2,008 10 40 46 2,070 11 41 47 2,071 12 46 48 2,117 13 50 49 2,338 14 55 50 2,710 15 73 51 3,104 16 75 52 3,432 17 80 53 3,690 18 82 54 3,910 19 89 55 4,091 20 91 56 4,132 21 91 57 4,851 22 94 58 5,419 23 97 59 5,565 24 116 60 5,630 25 131 61 5,664 26 137 62 5,801 27 151 63 5,965 28 154 64 6,282 29 174 65 6,797 30 200 66 7,435 31 215 67 8,817 32 226 68 9,094 33 250 69 9,319 34 258 70 10,189 35 273 71 11,534 36 275 72 11,698 1

Table S2. Oligonucleotide primers used in this study. Target microbes DNA Sequence (5-3 ) Total bacteria Fungi Bifidobacterium Bacteroides Enterococcus Staphylococcus Streptococcus E.coli Lactococcus lactis Lactobacillus L. helveticus L. salivarius L. gasseri CGGCAACGAGCGCAAC CC CCATTGTAGCACGTGTG TAGCC GAGGAAGTAAAAGTCG TAACAAGGTTTC CAAATTCACAAAGGGT AGGATGATT GCGTGCTTAACACATGC AAGTC CACCCGTTTCCAGGAG CTATT GAGAGGAAGGTCCCCC AC CGCTACTTGGCTGGTTC AG CCTTATTGTTAGTTGCC ATCATT ACTCGTTGTACTTCCCA TTGT GGCCGTGTTGAACGTG GTCAAATCA TIACCATTTCAGTACCTT CTGGTAA GAAGAATTGCTTGAATT GGTTGAA GGACGGTAGTTGTTGA AGAATGG CATGCCGCGTGTATGAA GAA CGGGTAACGTCAATGA GCAAA AGCAGTAGGGAATCTTC GGCA GGGTAGTTACCGTCACT TGATGAG AGCAGTAGGGAATCTTC CA CACCGCTACACATGGA G CTCTTCTCGGTCGCCTT G GAAGTGATGGAGAGTA GAGATTA TAAACAAAGTATTCGAT AAATGTACAGGTT GTCGTAACAAGGTAGC CGTAGGA TGCTATCGCTTCAAGTG CTT AGCGACCGAGAAGAGA Target gene 18s tuf tuf -23s -23s -23s -23s -23s Standard strain Escherichia coli ATCC 11775 Saccharomyces DSM 70412 Bifidobacterium ATCC 15700 bayanus breve Bacteroides fragilis ATCC 25285 Enterococcus canis DSM- 17029 Staphylococcus ATCC 12600 aureus Streptococcus salivarius subsp. thermophilus DSM 20617 Escherichia coli ATCC 11775 Lactococcus lactis subsp. hordniae DSM-20450 L. helveticus CGMCC 1.1877 L. helveticus CGMCC 1.1877 Reference (Denman & McSweeney, (Denman & McSweeney, (Zwielehner et al., 2009) (Zwielehner et al., 2009) (Collado et al., 2009) (Collado et al., 2009) (Collado et al., 2009) (Furet et al., 2009) L. salivarius DSM 20555 L. gasseri ATCC33323 2

L. ruminis L. buchneri L. sake L. acidophilus L. casei L. delbrueckii L. paracasei L. plantarum L. reuteri GAGA CACCGAATGCTTGCAYT CACC GCCGCGGGTCCATCCA AAA AGATTACTGACGCATTG GTTA GGACCAATGGAGCAAC TGAA GATAAGCGTGAGGTCG ATGGTT GAGCTAATCCCCCATAA TGAAACTAT GAAAGAGCCCAAACCA AGTGATT CTTCCCAGATAATTCAA CTATCGCTTA CTATAAGTAAGCTTTGA TCCGGAGATTT CTTCCTGCGGGTACTGA GATGT CACTTGTACGTTGAAAA CTGAATATCTTAA CGAACTCTCTCGGTCGC TTT ACATCAGTGTATTGCTT GTCAGTGAATAC CCTGCGGGTACTGAGAT GTTTC TGGATCACCTCCTTTCT AAGGAAT TGTTCTCGGTTTCATTAT GAAAAAATA ACCGAGAACACCGCGT TATTT CATAACTTAACCTAAAC AATCAAAGATTGTCT -23s -23s -23s -23s -23s -23s -23s -23s -23s L. ruminis DSM 20403 L.buchneri DSM 20057 L. sakei subsp. sakei DSM 20017 L. acidophilus DSM 20079 (Haarman & Knol, L. casei DSM 20011 (Haarman & Knol, L. delbrueckii subsp.indicus DSM 15996 L. paracasei subsp. paracasei DSM 5622 L. plantarum subsp. Argentoratensis DSM 16365 (Haarman & Knol, (Haarman & Knol, (Haarman & Knol, L. reuteri DSM 20016 (Haarman & Knol, 3

Table S3. Differences in bacterial quantities in the faecal and milk samples of healthy and mastitis cows. Microbial groups Milk Low SCC group Mean Median, Total bacteria 8.00±0.13 7.78, 6.69-10.35 Fungi 2.93±0.05 3.01, 2.35-3.30 Bacteroides 4.13±0.03 4.09, 3.70-4.53 E. coli 4.12±0.11 4.00, 3.16-6.34 Enterococcus 3.85±0.08 3.78, 3.13-5.26 Staphylococcus 5.03±0.12 4.93, 3.77-6.66 Streptococcus 5.77±0.08 5.85, 4.69-6.64 Bifidobacterium 3.46±0.07 3.40, 2.67-4.66 Lactobacillus 6.34±0.11 6.11, 5.28-7.97 Lactococcus 4.12±0.21 4.30, 2.14- lactis 6.16 L. salivarius 2.31±0.03 2.29, 2.04-2.96 L. sake 2.43±0.04 2.38, 2.15-3.42 L. ruminus 2.73±0.05 2.66, 2.30-3.75 L. reuteri 3.95±0.09 4.15, 2.07-4.24 L. plantarum 2.76±0.07 2.91, 1.95-3.62 L. paracasei 3.38±0.05 3.51, 2.73-3.90 L. helveticus 3.90±0.17 4.48, 1.90-4.77 High SCC group Mean Median, 8.77±0.15 9.02, 7.36-10.5 2.63±0.06 2.67, 1.73-3.11 3.72±0.04 3.74, 3.00-4.08 5.11±0.12 4.85, 4.30-7.14 4.92±0.13 4.90, 3.85-6.55 5.29±0.11 5.22, 4.38-6.63 6.04±0.1 6.22, 4.73-7.37 3.00±0.08 2.88, 2.40-4.30 5.97±0.08 5.97, 5.18-6.92 2.51±0.20 2.16, 1.14-6.84 1.90±0.04 1.89, 1.30-2.79 2.11±0.05 2.12, 1.18-2.62 2.34±0.04 2.30, 1.96-3.07 1.99±0.04 1.98, 1.41-2.65 1.88±0.06 1.88, 1.21-2.97 2.51±0.05 2.50, 1.87-3.21 1.97±0.07 1.95, 1.24-3.99 Faeces Response Low SCC group P-value of high Mean Median, SCC group 0.00043 11.63±0.10 11.71, 10.40-13.09 0.00021 6.04±0.06 6.04, 5.25-7.35 0.00000 9.23±0.08 9.17, 8.26-10.27 0.00000 7.15±0.08 7.17, 6.06-7.95 0.00000 7.47±0.07 7.38, 6.87-8.73 0.12980-6.46±0.06 6.43, 5.21-7.14 0.01007 7.05±0.13 7.39, 5.14-7.87 0.00002 6.92±0.08 6.88, 6.01-7.81 0.03471 8.04±0.08 8.09, 7.03-8.78 0.00000 5.02±0.08 5.00, 3.91-6.88 0.00000 5.29±0.07 5.30, 4.46-6.04 0.00000 4.62±0.05 4.59, 3.97-5.16 0.00000 4.74±0.05 4.74, 4.27-5.5 0.00000 4.90±0.07 4.95, 3.75-5.55 0.00000 4.82±0.07 4.81, 4.05-5.92 0.00000 4.46±0.09 4.48, 3.31-5.52 0.00000 5.00±0.05 5.00, 4.44-5.76 High SCC group Mean Median, 11.84±0.09 11.85, 10.69-12.80 6.05±0.07 6.05, 5.19-7.07 9.25±0.08 9.11, 8.56-10.36 6.93±0.07 6.87, 5.98-7.89 7.85±0.08 7.83, 7.00-8.82 6.54±0.08 6.53, 5.28-7.38 8.01±0.13 8.12, 6.17-8.90 6.90±0.09 6.68, 5.95-8.26 7.66±0.08 7.59, 6.36-8.88 5.09±0.08 5.06, 4.63-6.98 4.90±0.05 4.82, 4.42-5.68 4.13±0.08 4.15, 2.75-5.22 4.60±0.04 4.60, 4.22-5.08 4.87±0.05 4.84, 4.20-5.68 4.71±0.06 4.67, 4.22-5.74 4.43±0.06 4.42, 3.66-5.52 4.93±0.04 4.92, 4.18-5.43 Response P-value of high SCC group 0.11620-0.67280-0.96860-0.04322 0.00053 0.39520-0.00000 0.73970-0.00240 0.71430-0.00012 0.00000 0.03012 0.53190-0.14470-0.76540-0.25290-4

L. gasseri 3.65±0.04 3.62, 3.28-4.67 L. delbrueckii 2.90±0.05 2.96, 1.94-3.39 L. casei 3.76±0.10 3.77, 2.68-5.12 L. buchneri 3.41±0.04 3.37, 2.98-3.86 L. acidophilus 4.08±0.05 4.05, 3.56-5.08 3.72±0.04 3.72, 3.28-4.92 1.68±0.07 1.63, 0.86-2.83 3.19±0.09 3.08, 2.22-4.50 3.12±0.06 3.09, 2.45-4.39 3.84±0.05 3.76, 3.32-4.52 0.17120-4.73±0.06 4.73, 4.21-5.96 0.00000 4.77±0.05 4.77, 4.24-5.35 0.00017 5.52±0.09 5.43, 4.53-6.65 0.00000 4.42±0.05 4.39, 3.82-4.98 0.00071 5.45±0.05 5.45, 4.76-6.21 4.65±0.03 4.65, 4.14-5.05 4.63±0.03 4.63, 4.05-4.98 5.56±0.07 5.44, 4.85-6.60 2.78±0.16 2.48, 1.76-4.68 5.14±0.06 5.14, 4.02-5.79,, and - indicate increase, decrease, and no significant difference comparing bacterial quantity of low to high SCC group. Data are expressed in Log gene copy number per gram/ml of sample. 0.21730-0.00973 0.61630-0.00000 0.00012 5

Table S4. Spearman correlation between individual faecal Lactobacillus species and somatic cell count. Lactobacillus r P-value species L. buchneri -0.5449 0.0000 L. salivarius -0.3697 0.0014 L. casei 0.1248 0.2964 L. sake -0.4859 0.0000 L. gasseri -0.0612 0.6096 L. ruminis -0.2698 0.0219 L. reuteri -0.0465 0.6979 L. helveticus -0.1626 0.1724 L. acidophilus -0.4118 0.0003 L. paracasei 0.0195 0.8706 L. delbrueckii -0.2809 0.0168 L. plantarum -0.2025 0.0881 References Collado, M.C., Delgado, S., Maldonado, A. and Rodríguez, J.M., 2009. Assessment of the bacterial diversity of breast milk of healthy women by quantitative real-time PCR. Letters in Applied Microbiology 48: 523-528. Denman, S.E. and McSweeney, C.S., 2006. Development of a real-time PCR assay for monitoring anaerobic fungal and cellulolytic bacterial populations within the rumen. FEMS Microbiology and Ecology 58: 572-582. Furet, J.P., Firmesse, O., Gourmelon, M., Bridonneau, C., Tap, J., Mondot, S., Doré, J. and Corthier, G., 2009. Comparative assessment of human and farm animal faecal microbiota using real-time quantitative PCR. FEMS Microbiology and Ecology 68: 351-362. Haarman, M. and Knol, J., 2006. Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula. Applied and Environmental Microbiology 72: 2359-2365. Štšepetova, J., Sepp, E., Kolk, H., Lõivukene, K., Songisepp, E. and Mikelsaar, M., 2011. Diversity and metabolic impact of intestinal Lactobacillus species in healthy adults and the elderly. British Journal of Nutrition 105: 1235-1244. Zwielehner, J., Liszt, K., Handschur, M., Lassl, C., Lapin, A. and Haslberger, A.G., 2009. Combined PCR-DGGE fingerprinting and quantitative-pcr indicates shifts in fecal population sizes and diversity of Bacteroides, bifidobacteria and Clostridium cluster IV in institutionalized elderly. Experimental Gerontology 44: 440-446. 6